Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 3:15:1534682.
doi: 10.3389/fonc.2025.1534682. eCollection 2025.

Association of cumulative exposure to Chinese visceral adiposity index and gastrointestinal cancer: a prospective cohort study

Affiliations

Association of cumulative exposure to Chinese visceral adiposity index and gastrointestinal cancer: a prospective cohort study

Jiaxing Li et al. Front Oncol. .

Abstract

Background: Using the Kailuan Cohort, we investigated the association between cumulative exposure to the Chinese visceral adiposity index (CVAI) and the risk of developing gastrointestinal (GI) cancers.

Methods: A prospective cohort study was conducted among participants who underwent three consecutive health examinations in the Kailuan Cohort from 2006 to 2010. Participants were categorized into quartiles based on their cumulative CVAI (cumCVAI). The cumulative incidence of GI cancers was estimated using Kaplan-Meier curves. The dose-response relationship between CVAI and the risk of developing GI cancers was examined using restricted cubic spline (RCS) in multivariable adjusted models. Multivariate Cox proportional hazards regression analysis was performed to assess the association between cumCVAI quartiles and the incidence of GI cancers. Furthermore, subgroup analyses and sensitivity analyses were conducted.

Results: A total of 44,213 individuals were included in this study. The incidence rates of GI cancers per 1,000 person-years for the Q1 to Q4 groups were 1.00,1.45,1.62 and 2.11, respectively. The RCS curve demonstrated a significant dose-response relationship between cumCVAI and the occurrence of GI cancers events (P for overall trend < 0.001; P for nonlinear trend < 0.001). After adjusting for potential confounders, compared with the Q1 group, the risk of GI cancers was significantly elevated in the Q2 group (HR 1.26; 95% CI 1.01, 1.58), Q3 group (HR 1.31; 95% CI 1.05, 1.64), and Q4 group (HR 1.48; 95% CI 1.19, 1.85). This association was particularly evident in older individuals, females, those with a BMI ≥ 24 kg/m2, non-smokers, and non-drinkers.

Conclusion: Our findings demonstrate a significant association between high cumCVAI and an increased incidence of GI cancers. Prolonged maintenance of CVAI within optimal levels may serve as a potential preventive strategy for GI cancers.

Keywords: Chinese visceral adiposity index; cohort study; gastrointestinal cancer; visceral adipose tissue; visceral fat.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Screening flowchart.
Figure 2
Figure 2
Kaplan–Meier incidence rate of GI cancers by cumCVAI.
Figure 3
Figure 3
Restricted cubic spline of the association between cumCVAI and the risk of GI cancers.
Figure 4
Figure 4
Subgroup analysis of the association of cumCVAI with the risk of GI cancers.

Similar articles

References

    1. Arnold M, Abnet CC, Neale RE, Vignat J, Giovannucci EL, McGlynn KA, et al. Global burden of 5 major types of gastrointestinal cancer. Gastroenterology. (2020) 159:335–349.e315. doi: 10.1053/j.gastro.2020.02.068 - DOI - PMC - PubMed
    1. Cao W, Chen HD, Yu YW, Li N, Chen WQ. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020. Chin Med J (Engl). (2021) 134:783–91. doi: 10.1097/CM9.0000000000001474 - DOI - PMC - PubMed
    1. Murphy N, Jenab M, Gunter MJ. Adiposity and gastrointestinal cancers: epidemiology, mechanisms and future directions. Nat Rev Gastroenterol Hepatol. (2018) 15:659–70. doi: 10.1038/s41575-018-0038-1 - DOI - PubMed
    1. Belladelli F, Montorsi F, Martini A. Metabolic syndrome, obesity and cancer risk. Curr Opin Urol. (2022) 32:594–7. doi: 10.1097/MOU.0000000000001041 - DOI - PubMed
    1. Jayedi A, Rashidy-Pour A, Khorshidi M, Shab-Bidar S. Body mass index, abdominal adiposity, weight gain and risk of developing hypertension: a systematic review and dose-response meta-analysis of more than 2.3 million participants. Obes Rev. (2018) 19:654–67. doi: 10.1111/obr.12656 - DOI - PubMed

LinkOut - more resources